APVO-442

N/A

Report date: 2026/03/19 17:03:26

Base Information

Drug NameAPVO-442

Drug Alias NameAPVO 442APVO-442

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Anti-PSMA

TargetsT cell surface glycoprotein CD3Prostate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAptevo Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAptevo Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A